Response to: 'Tofacitinib for the treatment of polyarteritis nodosa: a literature review'. Correspondence on 'Tofacitinib for polyarteritis nodosa: a tailored therapy' by Rimar et al

Ann Rheum Dis. 2022 Oct;81(10):e205. doi: 10.1136/annrheumdis-2020-218790. Epub 2020 Sep 9.
No abstract available

Keywords: biological therapy; cytokines; systemic vasculitis.

Publication types

  • Review
  • Letter
  • Comment

MeSH terms

  • Humans
  • Piperidines
  • Polyarteritis Nodosa* / drug therapy
  • Pyrimidines / therapeutic use

Substances

  • Piperidines
  • Pyrimidines
  • tofacitinib